RUNX2 and pancreatic neoplasm: In the present study, we have found for the first time that siRNA-mediated silencing of RUNX2 enhances the cytotoxic effect of GEM on p53-mutated pancreatic cancer Panc-1 cells through the augmentation of TAp63-dependent cell death pathway.